Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReal Est.cred Regulatory News (RECI)

Share Price Information for Real Est.cred (RECI)

Share Price is delayed by 15 minutes
Get Live Data
116.50    1.00 (0.87%)
Bid:
115.00
Ask:
116.50
Spread: 1.50 (1.304%)
Market Cap: £257.52m
RECI Live PriceLast checked at - London Stock Exchange

Intraday Real Est.cred Share Chart

Update on Buyback Programme

31 Mar 2026 07:00

RNS Number : 7048Y
Real Estate Credit Investments Ltd
31 March 2026
 

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, TO ANY US PERSONS OR INTO, THE UNITED STATES, AUSTRALIA, CANADA, SOUTH AFRICA OR JAPAN, OR ANY OTHER JURISDICTION, OR TO ANY PERSON, WHERE DOING SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

 

31 March 2026

 

Real Estate Credit Investments Limited

("RECI" or the "Company")

Update on Buyback Programme

 

In September 2025, the Board of Directors of the Company announced an extension to its ongoing share buyback programme to run to 31 March 2026. A total of 650,000 ordinary shares of no par value each ("Ordinary Shares") have been purchased for treasury for an aggregate amount of £0.8 million, during the period from 1 October 2025 to 30 March 2026.

 

As previously announced, the Company considers all options when deciding on the appropriate allocation of the Company's available cash resources, including implementing share buybacks and investment in attractive high yielding opportunities to enhance RECI's returns.

 

The Company's principal focus has been on new and existing investment opportunities that can deliver an attractive yield to shareholders, particularly in the context of a steadily improving discount position since the commencement of the buyback programmes. During the current buyback programme, the Ordinary Shares traded at an average discount of 12.5 per cent. versus 13.1 per cent. over the previous programme.

 

Following expiry of the Company's current buyback programme, the Company will continue to consider share buybacks on an ongoing basis, utilising the Company's shareholder authority to purchase up to 33,231,931 ordinary shares granted at the Company's annual general meeting ("AGM") on 17 September 2025 (with a similar shareholder resolution expected to be tabled at the Company's next AGM).

 

The decision on whether to complete buybacks will be determined by available investment opportunities, the prevailing share price discount, available cash resources and considering prevailing market conditions. In periods of market volatility (such as we are currently experiencing), the Company will balance potential share buybacks versus maintaining appropriate levels of cash reserves. The Company will provide further updates on the progression of the buyback approach as part of its half-year and annual reports.

 

To complete the share buybacks, the Company will appoint Panmure Liberum to make market purchases of Ordinary Shares in on its behalf. Panmure Liberum will purchase the Ordinary Shares as principal (and not as agent) and sell them on to the Company. The Company intends that any Ordinary Shares purchased by the Company will be held in treasury.

 

Any share purchases will be made in accordance with certain pre-set parameters set out in the terms of Panmure Liberum's engagement, the general authority of the Company to repurchase shares granted by shareholders at the Company's 2025 annual general meeting; and the EU Market Abuse Regulation (596/2014) as it forms part of domestic law by virtue of section 3 of the European Union (Withdrawal) Act 2018 (as amended); and Chapter 9 of the Financial Conduct Authority's UK Listing Rules.

 

The maximum price payable per share (exclusive of expenses) must not exceed the higher of: (i) 105 per cent. of the average middle market quotations for the five business days preceding the date of purchase; and (ii) the higher of the last independent trade and the highest current independent bid on the London Stock Exchange.

 

A buy-back of Ordinary Shares on any trading day may represent a significant proportion of the daily trading volume in the Ordinary Shares on the Exchange (and could exceed the 25 per cent. limit of the average daily trading volume of the preceding 20 business days as referred to in the Commission Delegated Regulation (EU) No. 2016/1052 on buy-back programmes (as it forms part of UK law by virtue of the European Union (Withdrawal) Act 2018)).

 

Any purchase of Ordinary Shares by the Company will be notified through an RIS announcement in accordance with the UK Listing Rules. Shareholders should note that whether a buyback of Ordinary Shares is made is based on a number of factors and, accordingly, no expectation or reliance should be placed on Panmure Liberum exercising such discretion on any one or more occasions.

 

 

 

 

Enquiries:

Cheyne Capital Management (UK) LLP (Investment Manager)

+44 (0) 20 7968 7450

RECIIR@cheynecapital.com

 

 

 

Panmure Liberum (Corporate Broker)

+44 (0) 20 3100 2222

Darren Vickers/Alex Collins

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBRGDXIBXDGLG
Date   Source Headline
29th Nov 20182:23 pmRNSResult of EGM
6th Nov 20187:00 amRNSInv Mngr Fact Sheet and Q2 Investor Presentation
2nd Nov 20183:49 pmRNSPlacing Programme & Notice of EGM
8th Oct 20187:00 amRNSFactsheet Announcement
21st Sep 20183:13 pmRNSClose of Issue of New Ordinary Shares
20th Sep 201810:55 amRNSProposed Issue of New Ordinary Shares
18th Sep 20184:14 pmRNSResult of AGM
5th Sep 20187:00 amRNSFactsheet Announcement
13th Aug 20187:00 amRNSNotice of AGM
9th Aug 20187:00 amRNSDividend Declaration
7th Aug 20187:00 amRNSFact Sheet Annoucement
10th Jul 201810:53 amRNSNotification of Major Interest in Shares
5th Jul 20187:00 amRNSFactsheet Announcement
29th Jun 20183:20 pmRNSDirector Declaration
25th Jun 20184:15 pmRNSDirector/PDMR Shareholding
15th Jun 20187:00 amRNSDividend Declaration
15th Jun 20187:00 amRNSAnnual Financial Report
8th Jun 20189:17 amRNSFactsheet Announcement
1st Jun 20187:00 amRNSUpdate on Share Issue
22nd May 20187:00 amRNSProposed Issue of New Ordinary Shares
4th May 20187:00 amRNSFactsheet Announcement
18th Apr 20187:00 amRNSInvestment Manager Presentation
6th Apr 20187:00 amRNSFactsheet Announcement
19th Mar 20182:54 pmRNSDirector Declaration
9th Mar 20187:00 amRNSFactsheet Announcement
26th Feb 20183:22 pmRNSNotification of Major Interest in Shares
20th Feb 20184:19 pmRNSDividend Declaration
20th Feb 20184:16 pmRNSDirectorate Change
8th Feb 20187:00 amRNSInvestment Manager's Factsheet
8th Jan 20187:00 amRNSFact Sheet Announcement
3rd Jan 20182:35 pmRNSDirectorate Change
2nd Jan 20184:25 pmRNSNotification of Major Interest in Shares
29th Dec 201712:00 pmRNSKey Information Document
27th Dec 20174:03 pmRNSMajor Interest in Shares
27th Dec 20173:59 pmRNSMajor Interest in Shares
27th Dec 20177:00 amRNSNotification of Major Interest in Shares
21st Dec 20175:13 pmRNSDirector/PDMR Shareholding
19th Dec 20174:10 pmRNSNotification of Major Interest in Shares
18th Dec 20173:39 pmRNSNotification of Major Interest in Shares
15th Dec 20173:46 pmRNSClose of Issue of new Ordinary Shares
15th Dec 201712:31 pmRNSProposed Issue of new Ordinary Shares
6th Dec 20177:00 amRNSFact Sheet Announcement
1st Dec 20177:00 amRNSDividend Declaration
1st Dec 20177:00 amRNSHalf-year Report
7th Nov 20177:00 amRNSFact Sheet Announcement
6th Oct 20177:00 amRNSFact Sheet Announcement
5th Oct 20179:21 amRNSNotification of Major Interest in Shares
3rd Oct 20174:05 pmRNSNotification of Major Interest in Shares
3rd Oct 20174:01 pmRNSTotal Voting Rights
2nd Oct 20175:26 pmRNSNotification of Major Interest in Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.